No Data
TD Cowen Maintains Takeda Pharmaceutical(TAK.US) With Buy Rating
List of converted stocks (Part 2) [List of converted stocks for Parabolic Signal]
○List of stocks converting to Sell Market Code Stock Name Closing Price SAR Main Board <1720> Tokyu Construction 700 715 <1803> Shimizu Construction 1215 1248 <1878> Daito Construction 1767 518225 <1882> Toa Road 1280 1311 <1925> Daiwa House 4717 4849 <1928> Sekisui House 3579 3730 <1934> Euretec 1436 1472 <1952
Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases
Takeda Pharmaceutical: Revised Extraordinary Report
ADR Japanese stock rankings - general Sell pressure including Yuucho Bank, Chicago down 145 yen compared to Osaka at 39,255 yen.
Japanese stocks of ADR (American Depositary Receipt) compared to the Tokyo Stock Exchange (calculated at 153.48 yen per dollar) include Yu-cho Bank <7182>, SoftBank Group <9984>, Nidec <6594>, Renesas <6723>, Sony Group Corp <6758>, Murata Manufacturing <6981>, DAIKIN INDUSTRIES, LTD. Unsponsored ADR <6367>, all of which have declined, indicating a general trend towards Sell. The clearing price for Chicago Nikkei 225 Futures is down 145 yen from the Osaka daytime price, now at 39,255 yen. The U.S. stock market has fallen. The Dow Inc decreased by 267.58 dollars, now at 43,449.
Takeda Pharmaceutical (TAK.US) CD38 monoclonal antibody has been approved for clinical use again in China.
Takeda Pharmaceutical's CD38 monoclonal antibody has been approved for clinical use in China again.
